TSCAN THERAPEUTICS INC. - COMMON STOCK

TScan Therapeutics Announces Poster Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition

13 Dec 2021 09:16:14 By Nasdaq GlobeNewswire

TScan Therapeutics to Host a Virtual Event to Discuss Highlights from the 63rd ASH Annual Meeting and Exposition

03 Dec 2021 07:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics Establishes Facility to Manufacture T Cell Receptor Engineered T Cell Therapies

02 Dec 2021 07:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in Upcoming Investor Conferences

11 Nov 2021 07:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress

10 Nov 2021 07:00:02 By Nasdaq GlobeNewswire

TScan Therapeutics Announces Upcoming Presentations at the 63rd American Society of Hematology Annual Meeting and Exposition

04 Nov 2021 09:30:32 By Nasdaq GlobeNewswire

TScan Therapeutics Appoints Heather Savelle as Vice President, Investor Relations

05 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Chardan 5th Annual Genetic Medicines Conference

28 Sep 2021 07:00:00 By Nasdaq GlobeNewswire

TScan Therapeutics Appoints Zoran Zdraveski, J.D., Ph.D. as Chief Legal Officer

09 Sep 2021 16:05:00 By Nasdaq GlobeNewswire

TScan Therapeutics to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference

02 Sep 2021 07:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress

19 Aug 2021 07:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics to Present Discovery of T Cell Targets for COVID-19 at the Cell-Mediated Therapies for Infectious Disease Summit

21 Jul 2021 07:00:01 By Nasdaq GlobeNewswire

TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering

15 Jul 2021 18:59:22 By Nasdaq GlobeNewswire